Does DOAC use at discharge improve long-term outcomes in older patients with acute ischemic stroke and atrial fibrillation compared to warfarin?
In older patients with atrial fibrillation and acute ischemic stroke, discharging on a DOAC rather than warfarin is associated with better long-term outcomes.
In patients with acute ischemic stroke and AF, DOAC use at discharge was associated with better long-term outcomes relative to warfarin.
Xian et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: